Key references: Acute relapses of multiple sclerosis

  • Page E, Veillard D, Laplaud DA, Hamonic S, Wardi R, Lebrun C, et al. Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial. Lancet 2015;386(9997):974–81. https://www.ncbi.nlm.nih.gov/pubmed/26135706
  • Yamasaki R, Matsushita T, Fukazawa T, Yokoyama K, Fujihara K, Ogino M, et al. Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica. Mult Scler 2015;22(10):1337–48. https://www.ncbi.nlm.nih.gov/pubmed/26564994